Filing Details
- Accession Number:
- 0001179110-12-002709
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-02-15 16:35:23
- Reporting Period:
- 2012-02-14
- Filing Date:
- 2012-02-15
- Accepted Time:
- 2012-02-15 16:35:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 820237 | Gen Probe Inc | GPRO | Surgical & Medical Instruments & Apparatus (3841) | 330044608 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1230051 | M Phillip Schneider | Gen-Probe Incorporated 10210 Genetic Center Drive San Diego CA 92121 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-02-14 | 10,000 | $52.69 | 20,927 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-02-14 | 10,000 | $19.19 | 30,927 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-02-14 | 20,000 | $70.00 | 10,927 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2012-02-14 | 10,000 | $0.00 | 10,000 | $19.19 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2012-02-14 | 10,000 | $0.00 | 10,000 | $52.69 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2013-05-30 | No | 4 | M | Direct | |
| 0 | 2013-05-18 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2011.
- The shares subject to the stock option became fully vested and exercisable on May 30, 2006.
- The shares subject to the stock option became fully vested and exercisable on May 18, 2007.
Billionaire Hedge Funds
